With BYU partner, FSU's Magnet Lab researchers deciphering flu virusNovember 10, 2006TALLAHASSEE, Fla. - As the Northern Hemisphere braces for another flu season, researchers at Florida State University's National High Magnetic Field Laboratory are making strides toward better understanding the mechanics of the virus that causes it - a virus that kills between one-quarter and one-half million people each year. Tim Cross, director of the lab's Nuclear Magnetic Resonance (NMR) program, and collaborators from Brigham Young University are trying to understand the minute parts of the highly virulent Influenza Type A virus. To do that, they are using all of the magnet lab's NMR resources, including its 15-ton, 900-megahertz magnet, to produce a detailed picture of the virus's skin. "Using the magnet helps us build a blueprint for a virus's mechanics of survival," said Cross, who also is a professor of chemistry and biochemistry at FSU. "The more detailed the blueprint, the better our chances of developing drugs capable of destroying it." The only magnet of its kind in the world, the "900" is critical to the project's process. Otherwise, an image this complicated would be impossible to obtain. Cross and David Busath, a biophysicist at Brigham Young University, recently discovered key components of the protein holes, or "channels," in the influenza viral skin. These components lead to unique chemical reactions that are thought to be important clues for understanding how the channels regulate whether the virus can distribute its genes into host cells and reproduce or not. The researchers' findings were published recently in the Proceedings of the National Academy of Sciences. "This is a viral structure we haven't seen before," Busath said. "And yet, through these tiny little doors, acids must come in and DNA must go out if the virus is to survive. The idea is to block the door to prevent the normal function required for the virus to replicate." Once researchers understand how these channels are selective for acid, they can use that knowledge to fashion novel drugs capable of more effectively killing the virus. Florida State University |
|||||||||||||||||||||
| Related Flu Virus Current Events and Flu Virus News Articles Pushing light beyond its known limits Scientists at the University of Adelaide have made a breakthrough that could change the world's thinking on what light is capable of. When should flu trigger a school shutdown? As flu season approaches, parents around the country are starting to face school closures. But how bad should an influenza outbreak be for a school to shut down? Scientists discover influenza's Achilles heel: Antioxidants As the nation copes with a shortage of vaccines for H1N1 influenza, a team of Alabama researchers have raised hopes that they have found an Achilles' heel for all strains of the flu-antioxidants. NIAID scientists propose new explanation for flu virus antigenic drift Influenza viruses evade infection-fighting antibodies by constantly changing the shape of their major surface protein. TGen seeks emergency FDA approval of new swine flu test The Phoenix-based non-profit Translational Genomics Research Institute (TGen) announced today that, along with a business collaborator, it will submit a request to the U.S. Food and Drug Administration for emergency use of a new test to diagnose the 2009 H1N1 swine flu virus. Lessons from flu seasons past Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons. Triple-Combo Drug Shows Promise Against Antiviral-Resistant Swine Flu, UAB Researcher Says An experimental drug cocktail that includes three prescriptions now widely available offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu, says a virology researcher in the University of Alabama Birmingham (UAB) Division of Pediatric Infectious Diseases. Paradigm shift needed to combat drug resistance When people travel, bacteria and other infectious agents travel with them. As about a billion people cross international borders each year, many more billions of the bugs come along for the ride. Flu surveillance boosts control, treatment options, says UAB travel-clinic chief Because pandemics unfold in unpredictable ways, surveillance of travel-related illness is among the most powerful tools health officials and doctors can use to detect and respond to new pathogens like the novel H1N1 influenza, says the physician who heads the University of Alabama at Birmingham (UAB) Travelers' Clinic. NIH prepares to launch 2009 H1N1 influenza vaccine trial in people with asthma The National Institutes of Health is preparing to launch the first government-sponsored clinical trial to determine what dose of the 2009 H1N1 influenza vaccine is needed to induce a protective immune response in people with asthma, especially those with severe disease. More Flu Virus Current Events and Flu Virus News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||